Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion

BACKGROUND: Non Muscle Invasive Bladder Transitional Cancer (NMIBC) and Muscle Invasive Bladder Transitional Cancer (MIBC)/invasive have different gene profile and clinical course. NMIBC prognosis is not completely predictable, since the relapse rate is higher than 20%, even in the form of MIBC. The...

詳細記述

保存先:
書誌詳細
主要な著者: Franco, Renato, Zappavigna, Silvia, Gigantino, Vincenzo, Luce, Amalia, Cantile, Monica, Cerrone, Margherita, Facchini, Gaetano, Perdonà, Sisto, Pignata, Sandro, Di Lorenzo, Giuseppe, Chieffi, Sergio, Vitale, Giovanni, De Sio, Marco, Sgambato, Alessandro, Botti, Gerardo, Yousif, Ali Munaim, Novellino, Ettore, Grieco, Paolo, Caraglia, Michele
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4061920/
https://ncbi.nlm.nih.gov/pubmed/24893613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-33-48
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料